A paper published in Nature reports that by using non-viral targeted integration, researchers have prepared CD19 CAR-T cells (AAVS1-19bbz) that effectively eradicate tumor cells in the BL cell line Raji and cell line-derived xenograft mouse models [38]. This evidence concerns the gene CD19 and neoplasm.